| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.77B | 2.05B | 1.80B | 1.43B | 749.38M | 1.22B |
| Gross Profit | 468.72M | 705.68M | 776.11M | 484.33M | 27.23M | 536.70M |
| EBITDA | 808.47M | 1.14B | 1.07B | 739.83M | 211.34M | 629.55M |
| Net Income | 217.88M | 495.58M | 656.41M | 475.54M | -14.96M | 412.88M |
Balance Sheet | ||||||
| Total Assets | 5.71B | 6.22B | 5.88B | 4.78B | 4.12B | 3.92B |
| Cash, Cash Equivalents and Short-Term Investments | 191.65M | 417.56M | 315.75M | 490.81M | 115.51M | 177.36M |
| Total Debt | 3.24B | 3.75B | 3.46B | 2.37B | 2.37B | 2.20B |
| Total Liabilities | 3.39B | 3.88B | 3.61B | 2.51B | 2.46B | 2.31B |
| Stockholders Equity | 2.33B | 2.34B | 2.28B | 2.27B | 1.65B | 1.61B |
Cash Flow | ||||||
| Free Cash Flow | 846.07M | -178.84M | -775.24M | 52.93M | -399.47M | -120.26M |
| Operating Cash Flow | 858.43M | 736.41M | 856.18M | 370.89M | 62.93M | 604.06M |
| Investing Cash Flow | 75.01M | -483.40M | -1.24B | -239.47M | -363.06M | -715.97M |
| Financing Cash Flow | -1.00B | -147.80M | 433.07M | 10.03M | 223.55M | 124.18M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $2.78B | 12.84 | 11.43% | 6.12% | -23.59% | -57.70% | |
72 Outperform | $3.06B | 9.62 | 9.63% | 3.19% | -35.37% | -57.86% | |
72 Outperform | $2.13B | 10.66 | 18.81% | 6.12% | -16.45% | 23.94% | |
70 Neutral | $5.85B | 26.86 | 9.32% | 4.32% | -13.41% | -60.18% | |
68 Neutral | $2.08B | 6.68 | 17.02% | 3.72% | -20.11% | -26.44% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
56 Neutral | $4.14B | 69.39 | 2.99% | 2.68% | 19.15% | 329.74% |
On 8 December 2025, Frontline plc held its 2025 Annual General Meeting in Limassol, Cyprus, where shareholders received the audited consolidated financial statements for the year ended 31 December 2024 and voted on a series of governance and capital-related resolutions. Shareholders re-elected six directors, elected a new director, re-appointed PricewaterhouseCoopers as auditor with discretion for the board to set fees, and approved total board remuneration not exceeding USD 600,000 for 2025. The meeting also backed two key resolutions excluding shareholders’ pre-emption rights for 12 months from 8 December 2025 on potential public offerings of up to 377,377,111 new ordinary shares and an equivalent volume of convertible securities or options, at a minimum subscription price of USD 1 per security, thereby giving the board substantial flexibility to raise equity or equity-linked capital. In addition, shareholders approved, on an advisory basis, the company’s remuneration report for 2024, reinforcing support for the current executive pay framework and governance structure.
The most recent analyst rating on (FRO) stock is a Sell with a $145.00 price target. To see the full list of analyst forecasts on Frontline stock, see the FRO Stock Forecast page.